Netflix issued a flat denial Tuesday after Lionsgate shares surged 14% on acquisition speculation — but the denial doesn't close the story. Lionsgate is positioned as a pure-play acquisition target following its May 2025 separation from Starz, with a stock that's climbed from ~$6 to over $16 since the split. That success raises the acquisition floor at a moment when Hollywood consolidation is accelerating fast. This episode breaks down what the Netflix denial actually signals, what Lionsgate's IP slate is worth to a strategic buyer, and where the broader M&A wave is heading.
Netflix issued a flat denial Tuesday after Lionsgate shares surged 14% on acquisition speculation — but the denial doesn't close the story. Lionsgate is positioned as a pure-play acquisition target following its May 2025 separation from Starz, with a stock that's climbed from ~$6 to over $16 since the split. That success raises the acquisition floor at a moment when Hollywood consolidation is accelerating fast. This episode breaks down what the Netflix denial actually signals, what Lionsgate's IP slate is worth to a strategic buyer, and where the broader M&A wave is heading.
Key Takeaways:
Lionsgate remains the most legible remaining standalone acquisition target in Hollywood. The denial from Netflix is data, not resolution. For agents, producers, and executives whose deal universe depends on knowing who the next buyer is — the rights entanglement question is the variable to track. How that shakes out in due diligence will set the ceiling on any eventual deal price. Watch the fall slate performance and any movement from private equity or strategic buyers on Imax as a parallel signal for where appetite is forming.
Subscribe to The Option for daily updates on the business behind the business.
The Option is a daily intelligence briefing on the business of Hollywood—not the headlines, but what drives them.
Each episode breaks down the deals, power dynamics, and economics that shape film, television, and streaming. From studio mergers and executive shuffles to talent leverage and IP strategy, The Option explains why decisions get made, not just what happened.
This is not entertainment news. This is industry intelligence.
Hosted by a senior industry insider, The Option delivers 3-6 minutes of sharp, informed analysis for executives, investors, talent representatives, producers, and anyone who wants to understand how Hollywood actually operates.
Topics include:
• Studio economics & streaming profitability
• Mergers, acquisitions & media consolidation
• Talent agency power & packaging dynamics
• Executive strategy & leadership transitions
• Awards season as a business function
• IP valuation & library economics
• Release windows & distribution strategy
• Private equity in entertainment
New episodes drop daily. No gossip. No fan takes. Just the business behind the business.
Subscribe for the intelligence that moves the industry.